Origin Therapeutics Holdings (XCNQ:ORIG) Total Operating Expense : C$0.74 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Total Operating Expense?

Origin Therapeutics Holdings's Total Operating Expense for the three months ended in Jun. 2023 was C$0.09 Mil. Origin Therapeutics Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.74 Mil.

Origin Therapeutics Holdings Total Operating Expense Historical Data

The historical data trend for Origin Therapeutics Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Total Operating Expense Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Total Operating Expense

1.02

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Operating Expense	Get a 7-Day Free Trial				0.22	0.31	0.13	0.21	0.09

Origin Therapeutics Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.74 Mil.

Origin Therapeutics Holdings Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.